ACUTE LEUKEMIA
Clinical trials for ACUTE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a cancer drug fix an irregular heartbeat?
Disease control CompletedThis study looked at whether Vidaza, a drug used for acute leukemia, could also help treat atrial fibrillation (an irregular heartbeat). The idea was that Vidaza might reverse harmful DNA changes in heart cells, reducing scarring and improving heart rhythm. Only one person took p…
Matched conditions: ACUTE LEUKEMIA
Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated May 26, 2026 04:52 UTC
-
New combo aims to tame transplant complications in blood cancer
Disease control CompletedThis study tested whether adding an experimental drug (VIC-1911) to standard medications can prevent graft-versus-host disease (GVHD) and relapse in adults with blood cancers like leukemia or lymphoma who receive a stem cell transplant. Sixteen participants were enrolled. The goa…
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 26, 2026 04:50 UTC
-
Could a drug make stem cell transplants safer for blood cancer patients?
Disease control CompletedThis study tested a drug called palifermin in 34 adults with blood cancers who received stem cells from an unrelated donor. The goal was to see if palifermin could reduce severe graft-versus-host disease (GVHD), a common complication where donor cells attack the patient's body. P…
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 04:48 UTC
-
New drug combo may reduce deadly transplant complication in blood cancer patients
Disease control CompletedThis study tested whether adding the drug itacitinib to the usual two-drug regimen (tacrolimus and sirolimus) could better prevent graft-versus-host disease (GVHD) in 59 adults with blood cancers (acute leukemia, myelodysplastic syndrome, or myelofibrosis) undergoing a donor stem…
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Supercharged cord blood transplant shows promise for faster recovery in blood cancer patients
Disease control CompletedThis study tested a special stem cell product called NiCord, made by growing cord blood cells in a lab to increase their number. It was compared to standard cord blood transplants in 125 people with blood cancers like leukemia and lymphoma. The goal was to see if NiCord could hel…
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE3 • Sponsor: Gamida Cell ltd • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Beauty treatments ease anxiety for isolated blood cancer patients
Symptom relief CompletedThis study looked at whether aesthetic therapy (like skincare and relaxation) can reduce anxiety and improve quality of life for patients with acute leukemia or those who had a stem cell transplant. These patients are isolated in a special hospital area for at least 28 days. The …
Matched conditions: ACUTE LEUKEMIA
Phase: NA • Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated May 22, 2026 14:05 UTC
-
Leukemia patients' clotting clues revealed in new study
Knowledge-focused CompletedThis study looked at levels of four blood clotting proteins (antithrombin III, protein C, protein S, and D-dimer) in 60 people with acute leukemia and 30 healthy volunteers. The goal was to see if these levels differ between leukemia patients and healthy people. No treatment was …
Matched conditions: ACUTE LEUKEMIA
Sponsor: Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy • Aim: Knowledge-focused
Last updated May 26, 2026 04:35 UTC
-
Blood cancer study aims to unlock predictive clues
Knowledge-focused CompletedThis study looked at 650 adults with acute leukemia, myelodysplastic syndromes, or myeloproliferative disorders. Researchers collected blood, bone marrow, skin, and cheek cell samples to analyze genes, drug responses, and immune markers. The goal was to find factors that predict …
Matched conditions: ACUTE LEUKEMIA
Phase: NA • Sponsor: Institut Paoli-Calmettes • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC